depression drug

Monday, March 05, 2007

GSK boost as it plans China venture



This is Money - GSK faces copycat competition to anti-depression drug Wellbutrin and Zofran, which treats vomiting. But it will supplement lost sales with the introduction of Tykerb, a new drug for late stage breast cancer and Cervarix, a wannabe blockbuster
Source: www.thisismoney.co.uk

Wyeth depression/hot flash drug faces hurdles
SignOn San Diego - NEW YORK – Wyeth could win U.S. approval Monday for a depression drug derived from the company's widely used Effexor XR, but its launch will be delayed by factory problems and issues with nausea, according to Wyeth and industry analysts. The
Source: www.signonsandiego.com

Industry Wrapups
Boston Business Journal - in Mass, R.I. [Thursday] Charles River Assoc. profit rose in Q2 [Thursday] EMC reaffirms outlook, buys back shares [Thursday] InfoUSA caps purchase of OneSource Information [Thursday] NEWBO names LaPlante-Dube new president [Thursday] Repligen depression drug
Source: boston.bizjournals.com

EntreMed cancer drug deemed safe
Pharmaceutical Business Review - EntreMed has revealed that an an independent Data Safety Monitoring Board has conducted a favorable review of safety data from its breast cancer drug. The review was undertaken to assess the safety of the drug, MKC-1 in a phase II trial in patients
Source: www.pharmaceutical-business-review.com

How about men troubled ..
Town Hall - After controlling for factors such as socio-economic status and home life, they found “significant differences” between those who had had an abortion and those who had not. There were greater instances of depression, drug use, suicidal thoughts
Source: www.townhall.com


Click here for more information about depression clinic depression clinic